Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

TesamorelinvsIpamorelin

The only FDA-approved peptide specifically designed to melt away stubborn belly fat by telling your brain to release more growth hormone naturally—working with your body's own systems rather than replacing them.

A uniquely selective growth hormone booster that tells your pituitary to release more GH without messing with your cortisol or other hormones—making it the 'clean' choice among growth hormone peptides.

Growth HormoneGrowth Hormone

At a Glance

Quick
comparison

Dose Range

Tesamorelin

1–2 mg

Ipamorelin

100–300 mcg

Frequency

Tesamorelin

Once daily

Ipamorelin

Multiple times daily

Administration

Tesamorelin

Subcutaneous injection

Ipamorelin

Subcutaneous injection

Cycle Length

Tesamorelin

12+ weeks

Ipamorelin

8-12 weeks

Onset Speed

Tesamorelin

Moderate (1-2 weeks)

Ipamorelin

Moderate (1-2 weeks)

Evidence Level

Tesamorelin

Strong human trials (Phase 3 or FDA approved)

Ipamorelin

Moderate human trials (Phase 1-2)

Efficacy

Benefit
ratings

Tesamorelin
Ipamorelin

Visceral Fat Reduction

Tesamorelin96%
Ipamorelin0%

Metabolic Health

Tesamorelin89%
Ipamorelin0%

Natural GH Boost

Tesamorelin92%
Ipamorelin0%

GH Selectivity

Tesamorelin0%
Ipamorelin98%

Recovery Support

Tesamorelin0%
Ipamorelin90%

Safety Profile

Tesamorelin0%
Ipamorelin92%

Technical Data

Compound
specifications

Tesamorelin

Molecular Formula

C221H366N72O67S

Molecular Weight

5135.86 g/mol

Half-Life

26-38 minutes

Bioavailability

~100% (subcutaneous injection)

CAS Number

218949-48-5

Ipamorelin

Molecular Formula

C38H49N9O5

Molecular Weight

711.85 g/mol

Half-Life

2 hours

Bioavailability

High when injected subcutaneously

CAS Number

170851-70-4

Protocols

Dosing
tiers

Tesamorelin

starting

1 mg

Once daily

2-4 weeks

Some practitioners start at the lower approved dose to assess tolerance before increasing. The standard FDA-approved dose is 2mg, but starting lower allows you to monitor for side effects like injection site reactions or joint discomfort.

standard

2 mg (or 1.4 mg Egrifta SV)

Once daily

26 weeks or longer

This is the FDA-approved dose shown effective in large Phase 3 trials. Clinical studies showed significant visceral fat reduction at 26 weeks with continued benefits at 52 weeks. Note: Egrifta SV uses a 1.4mg dose which is bioequivalent to the original 2mg formulation.

advanced

2 mg

Once daily

52+ weeks

Long-term use beyond the initial 26 weeks has been studied and shows maintained benefits. However, stopping treatment causes visceral fat to return. Many users continue indefinitely with periodic monitoring. Extended use requires regular IGF-1 and glucose monitoring.

Ipamorelin

starting

100 mcg

2-3 times daily

4-8 weeks

Start low to assess your body's response. Inject on an empty stomach for best absorption. Many people start with just twice daily (morning and before bed) to keep things simple.

standard

200 mcg

2-3 times daily

8-12 weeks

The sweet spot for most users. Injecting 200 mcg three times daily (morning, post-workout, and bedtime) maximizes GH pulses throughout the day while staying well-tolerated.

advanced

300 mcg

3 times daily

8-12 weeks

Higher doses for those who've established tolerance. Some research used up to 1mg/kg, but most users find diminishing returns above 300 mcg per dose. Always combine with proper nutrition and training.

Applications

Best
suited for

Tesamorelin

People with Stubborn Visceral Fat

If you carry your weight around your midsection—the deep belly fat that wraps around your organs—tesamorelin is specifically designed for you. Unlike weight loss drugs, it targets visceral fat while preserving the normal subcutaneous fat that's healthy to have.

HIV Patients with Lipodystrophy

Tesamorelin is FDA-approved specifically for HIV-associated lipodystrophy—the abnormal fat accumulation in the belly that antiretroviral medications can cause. It's the only treatment proven to help this condition, reducing both the physical and psychological burden.

Those Concerned About Metabolic Health

Visceral fat isn't just cosmetic—it's metabolically dangerous, linked to heart disease, diabetes, and inflammation. By reducing visceral fat, tesamorelin also improves triglycerides, cholesterol ratios, and may help protect your liver from fatty liver disease.

Adults Wanting Natural GH Stimulation

Unlike synthetic growth hormone injections, tesamorelin works WITH your body's natural systems. It tells your pituitary to release more of YOUR OWN growth hormone, maintaining normal feedback loops and reducing the risks associated with supraphysiological GH levels.

Ipamorelin

Clean GH Boost Seekers

If you want the benefits of increased growth hormone without spiking cortisol or other stress hormones, Ipamorelin is uniquely selective. Unlike GHRP-2 or GHRP-6, it won't raise your cortisol levels even at doses 200 times higher than needed for GH release.

Recovery-Focused Athletes

Ipamorelin shines for athletes who want better recovery between training sessions. The GH boost helps repair muscle tissue faster, and since it doesn't mess with other hormones, you can use it consistently without the rollercoaster effects.

Anti-Aging Enthusiasts

Growth hormone naturally declines as we age, contributing to muscle loss, fat gain, and reduced vitality. Ipamorelin offers a gentle way to restore more youthful GH levels without the risks of actual HGH therapy.

Those Recovering from Steroid Use

Research shows Ipamorelin can help counteract the muscle and bone-weakening effects of glucocorticoid medications. If you've been on steroids for medical reasons, this peptide may help you rebuild what you've lost.

Safety Profile

Side
effects

Tesamorelin

Common

  • Injection site reactions
  • Joint pain (arthralgia)
  • Muscle pain (myalgia)
  • Peripheral edema

Uncommon

  • Carpal tunnel symptoms
  • Elevated blood glucose

Serious

  • Severe allergic reaction
  • Worsening diabetes

Ipamorelin

Common

  • Mild headache
  • Injection site reactions
  • Water retention
  • Increased appetite

Uncommon

  • Tingling in hands or feet
  • Joint stiffness

Serious

  • Allergic reaction

Research Status

Safety
& evidence

Tesamorelin

Evidence Level

Strong human trials (Phase 3 or FDA approved)

FDA Status

FDA approved for other use

Safety Overview

Tesamorelin has a strong safety profile backed by FDA approval and multiple large Phase 3 clinical trials involving over 800 patients. The most common issues are injection site reactions and the typical side effects of elevated growth hormone (joint pain, fluid retention). Glucose metabolism should be monitored as some patients experience increased blood sugar. Long-term cardiovascular safety data is still being collected, which is why the FDA recommends reassessing treatment if visceral fat doesn't reduce.

Contraindications

  • xActive malignancy or history of cancer (pituitary tumors especially)
  • xKnown hypersensitivity to tesamorelin or mannitol
  • xPregnancy
  • xDisruption of the hypothalamic-pituitary axis from conditions like hypophysectomy or pituitary tumor surgery

Ipamorelin

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

Research compound

Safety Overview

Ipamorelin has shown a favorable safety profile in both animal and human studies. What makes it stand out is its remarkable selectivity—it releases growth hormone without significantly affecting cortisol, ACTH, or other hormones. In clinical trials, it was well-tolerated with mostly mild, temporary side effects. Phase 2 trials in patients recovering from surgery showed no significant safety concerns compared to placebo.

Contraindications

  • xActive cancer or history of cancer
  • xPregnancy or breastfeeding
  • xPituitary disorders or tumors
  • xKnown allergy to peptide components
  • xChildren and adolescents (growth plates still open)

Decision Guide

Which is
right for you?

Choose Tesamorelin if...

  • Reducing visceral abdominal fat
  • Improving metabolic health markers
  • Supporting natural growth hormone production
  • Addressing HIV-associated lipodystrophy

Choose Ipamorelin if...

  • Muscle recovery and growth
  • Anti-aging and vitality
  • Body composition improvement
  • Sleep quality enhancement
Peptide ProTesamorelin vs Ipamorelin — Peptide Comparison | Peptide Initiative